Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000107 · ClinicalTrials.gov registry record
Body Water Content in Cyanotic Congenital Heart Disease
A clinical trial, sponsored by National Center for Research Resources (NCRR).
- Completed
- Registry status
NCT00000107 is a clinical trial that has completed, run by National Center for Research Resources (NCRR).
The verdict
NCT00000107 has completed, sponsored by National Center for Research Resources (NCRR).
- COMPLETED
- Registry status
Study Summary
Adults with cyanotic congenital heart disease have elevated levels of plasma proatrial natruretic peptide (proANP) which most likely results in chronic dehydration, leading to reduced oxygen transport to tissues and shortness of breath with activity. The purpose of this study is to characterize adults with cyanotic congenital heart defects with respect to their body composition (water and fat-free mass) and resting metabolic rates. The study consists of several measures of how much body water, fat and lean tissue a subject has, and measures the number of calories the subject's body uses at rest. Adult subjects with cyanotic congenital heart disease will be recruited along with healthy noncyanotic control subjects matched for age, gender, and body weight.
Trial Details
| Field | Value |
|---|
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00000107
The ClinicalTrials.gov registry entry for NCT00000107 describes a study currently listed as completed, categorized as an unspecified phase. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Center for Research Resources (NCRR), which has 94 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00000107 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00000107 about?
NCT00000107 is a clinical study titled "Body Water Content in Cyanotic Congenital Heart Disease". Adults with cyanotic congenital heart disease have elevated levels of plasma proatrial natruretic peptide (proANP) which most likely results in chronic dehydration, leading to reduced oxygen transport to tissues and shortness of breath with activity. The purpose of this study is to characterize adul...
What is the current status of trial NCT00000107?
This trial is currently completed.
Who is sponsoring clinical trial NCT00000107?
This trial is sponsored by National Center for Research Resources (NCRR), which has 94 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.